BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heredia N, Escobar M, Rodríguez-Padilla C, García S. Extracts of Haematoxylon brasiletto inhibit growth, verotoxin production, and adhesion of enterohemorrhagic Escherichia coli O157:H7 to HeLa cells. J Food Prot 2005;68:1346-51. [PMID: 16013369 DOI: 10.4315/0362-028x-68.7.1346] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Upadhyay A, Upadhyaya I, Kollanoor-Johny A, Venkitanarayanan K. Combating pathogenic microorganisms using plant-derived antimicrobials: a minireview of the mechanistic basis. Biomed Res Int 2014;2014:761741. [PMID: 25298964 DOI: 10.1155/2014/761741] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 8.8] [Reference Citation Analysis]
2 Bello-Martínez J, Jiménez-Estrada M, Rosas-Acevedo JL, Avila-Caballero LP, Vidal-Gutierrez M, Patiño-Morales C, Ortiz-Sánchez E, Robles-Zepeda RE. Antiproliferative activity of Haematoxylum brasiletto H. Karst. Pharmacogn Mag 2017;13:S289-93. [PMID: 28808394 DOI: 10.4103/pm.pm_466_16] [Reference Citation Analysis]
3 Nava-Tapia DA, Cayetano-Salazar L, Herrera-Zúñiga LD, Bello-Martínez J, Mendoza-Catalán MA, Navarro-Tito N. Brazilin: Biological activities and therapeutic potential in chronic degenerative diseases and cancer. Pharmacol Res 2021;175:106023. [PMID: 34883212 DOI: 10.1016/j.phrs.2021.106023] [Reference Citation Analysis]
4 Sitarek P, Merecz-Sadowska A, Kowalczyk T, Wieczfinska J, Zajdel R, Śliwiński T. Potential Synergistic Action of Bioactive Compounds from Plant Extracts against Skin Infecting Microorganisms. Int J Mol Sci 2020;21:E5105. [PMID: 32707732 DOI: 10.3390/ijms21145105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
5 Sánchez E, García S, Heredia N. Extracts of edible and medicinal plants damage membranes of Vibrio cholerae. Appl Environ Microbiol 2010;76:6888-94. [PMID: 20802077 DOI: 10.1128/AEM.03052-09] [Cited by in Crossref: 127] [Cited by in F6Publishing: 37] [Article Influence: 10.6] [Reference Citation Analysis]
6 Rahal EA, Fadlallah SM, Nassar FJ, Kazzi N, Matar GM. Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype. Front Cell Infect Microbiol 2015;5:24. [PMID: 25853096 DOI: 10.3389/fcimb.2015.00024] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]